Identifying applicants who will be successful dermatology residents requires a tremendous effort every year. The objective of the current study was to determine if application characteristics are predictive of success in dermatology residency. We conducted a retrospective cohort study utilizing applications of dermatology residents from the University of Michigan (2011-2016) and Wayne State University (2009-2019). The residents' clinical abilities and collegiality were retrospectively assessed by faculty based on a scale from 1 (Problematic, I would not recommend this person as a colleague or physician) to 4 (Great, I would love to have this person as a colleague and would recommend this person to family and friends as a physician). The relationship between faculty ratings and application characteristics was evaluated through multivariable regression. Ninety-one total residents were included in the study, with 48 from University of Michigan and 43 from Wayne State University . Nine faculty from University of Michigan and six faculty from Wayne State University evaluated residents. The average faculty rating of residents was 2.5 ± 0.5. Board examination scores were associated with higher faculty ratings (Step 1, β: 0.007; 95% CI: 0.001, 0.013; P = .03; Step 2, β: 0.008; 95% CI: 0.001, 0.014; P = .02). High level of athletic achievement was also associated with higher average faculty ratings (β: 0.310; 95% CI: 0.051, 0.569; P = .02). Our study suggests that board examination scores and athletic achievement are associated with success in dermatology residency. Further research is needed to fully understand the relationship between these factors and their utility in evaluating prospective candidates.
We analyzed dermatology retraction trends (2006-2024) by examining causes, geographic distribution, journal metrics, and citation patterns. Our purpose was to identify systemic issues and propose solutions to enhance research integrity and mitigate postretraction citation risks in the field. A bibliometric analysis was conducted on 280 retracted dermatology contributions from the Retraction Database (2006-2024), supplemented by Scopus for publication and citation data. The annual number of retractions showed a highly significant increase over the period, peaking at 74 in 2023. Academic misconduct (data fabrication/tampering and plagiarism) was the leading cause, accounting for 45% of all retractions. United States had the highest absolute count (n = 80), whereas China exhibited the highest normalized retraction rate (357 per 10,000 publications), contrasting sharply with the US rate (19.7 per 10,000). Postretraction citation analysis (n = 80 contributions) revealed a high proportion of inappropriate citations (30%). The sharply increasing retraction trend, driven largely by misconduct and geographic disparities, requires urgent, multilevel interventions, including stricter oversight, ethical training, and improved peer review. Addressing postretraction citations is critical to curbing misinformation.
Treatment of keloids and hypertrophic scars poses a significant challenge. Several treatments are beneficial, including surgery, technologies such as lasers, medication injections (eg, triamcinolone and antineoplastic drugs), cryotherapy, and radiation, but recurrence rates are high after all of these procedures. The ASAP algorithm is a rational, sequential, nonsurgical approach to treating keloids and hypertrophic scars, described by the authors several years ago; after applying it, recurrence rates are very low. ASAP stands for the following steps: A, assessment of the keloid or hypertrophic scar; S, soften the lesion using occlusive dressings; A, approach the scar or keloid utilizing a combination of technologies and injectable antifibrosant drugs; and finally, P, pigmentary alteration treatment. This algorithm was initially popularized in Brazil and has been adopted at several centers; however, with the advent of new technologies and drugs to treat keloids and hypertrophic scars, it has undergone significant improvement. This overview offers an updated perspective on the ASAP sequential algorithm. New research data, including the benefits of microneedling and medications such as verapamil and botulinum toxin, as well as the improvement of hyperpigmentation with picosecond laser, have been incorporated into the ASAP protocol. The importance of integrating diverse therapeutic modalities is highlighted. This sequential stepwise approach promotes gradual clinical improvement while minimizing the likelihood of recurrence.
Acne affects almost 10% of the world's population, and sufferers are often stigmatized; yet, media portrayals of the condition have received little academic attention. Media depictions can shape public views about medical disorders. This study examined the portrayal of acne in readily accessible cartoons to creatively inform education campaigns about the condition. The image sections of various internet search engines and the online cartoon library CartoonStock were inspected for single-panel cartoons that made specific reference to acne. Each cartoon was then examined according to an instrument with categories for describing the themes about acne, the suggested etiology, treatment methods, and outcome. Ninety-three cartoons were identified. Common themes included acne causing despair for sufferers, being fervently hidden from others, and impairing the formation of intimate relationships. No cartoon made reference to retinoids or other newer acne treatments, and positive outcomes were rarely depicted. It is hoped that future cartoon portrayals of acne may be able to offer more optimistic messages about the condition.
Red marble is a rare limestone found in the Ore Mountains of Saxony, Germany. It was used by a court goldsmith, Johann Heinrich Köhler (1669-1736), to create a sculpture for King Augustus the Strong (1670-1733) and for his widely known Green Vault in the Royal Palace of Dresden. This treasured small figure of a disabled Swedish Grenadier depicts the bloody experience of the battlefield during the Great Northern War (1700-1721) in the German States. The grenadier sculpture also conveys a positive message to the viewer, intended to guide the prevention of death and suffering-an art object for peace.
This contribution presents 14 dermatology-related eponyms that honor the patients who helped define the clinical entities and disorders that bear their names or initials. These clinical entities and disorders include: (1) anti-La antibodies, (2) anti-Ro antibodies, (3) anti-Sm antibodies, (4) B-K mole syndrome, (5) Hela cells, (6) Carrion disease, (7) Christmas disease, (8) Cowden syndrome, (9) Hageman disease, (10) Hartnup disease, (11) Mortimer malady, (12) rickettsiosis, (13) Schamroth sign, and (14) Trousseau syndrome.
Nanodermatology is the application of nanotechnology specifically to dermatology. We discuss the pros and cons of translating these innovations into routine dermatology practice, as well as the unique safety challenges, regulatory issues, and ethical and equity concerns surrounding nanodermatology. Unlike other emerging technologies, nanodermatology involves transcutaneous exposure to engineered nanoparticles that may penetrate beyond the epidermis, persist in tissues, and accumulate systemically. These characteristics create distinct safety and ethical challenges, including invisible patient exposure, uncertain long-term toxicologic effects, and unequal regulatory oversight across countries. The specific ethical issues involve nonmaleficence, informed consent, privacy, autonomy, and justice.
The risk of skin cancer in persons living with HIV (PLWH) is an evolving subject area shaped by the use of antiretroviral therapy. Keratinocyte carcinomas, including basal and squamous cell carcinoma, have a high incidence in the general population and in PLWH. PLWH may have a higher risk of squamous cell carcinoma compared to the general population. In addition, Merkel cell carcinoma and sebaceous carcinoma exhibit higher incidence rates in PLWH. Data on melanoma risk are varied. Risks of skin cancer may be influenced by vigilant surveillance, photosensitivity, and immune status. Screening for skin cancer is generally recommended, although national guidelines vary in specific recommendations. Treatments range from topical therapies to surgeries to immune checkpoint inhibitors, with Mohs micrographic surgery playing an important role. Data on immune checkpoint inhibitors suggest safe and efficacious use in PLWH, although larger trials are warranted. The dynamic interplay between HIV, antiretroviral use and immunosuppression, and the risk and treatment of skin cancer underscores the importance of rigorous research studies and screening and treatment guidelines specific to this population.

